Biomarkers · Inflammation
Procalcitonin
Lower values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).
Procalcitonin and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to the curve's reference value, drawn from the published study (source below).
Published risk of death1.52×men, highest vs lowest quartile of PCT (95% CI 1.07–2.16) · Malmö Diet and Cancer cohort, Sweden, 3,322 adults without CVD or cancer; estimate is for the men subgroup (no significant association in women)
Sources
- Risk curve: Cotoi OS 2013 (PMID 23937962): all-cause HR 1.52 (1.07-2.16) men, highest vs lowest quartile of PCT. Scaled to published population values.
- Cotoi OS, Manjer J, Hedblad B, Engström G, Melander O, Schiopu A. Plasma procalcitonin is associated with all-cause and cancer mortality in apparently healthy men: a prospective population-based study. BMC Med. 2013;11:180.
Map Procalcitonin against another biomarker.
Related markers: Alpha-1-Antichymotrypsin (AACT) · Alpha-1-Antitrypsin (AAT) · Antinuclear Antibodies (ANA) · CD4:CD8 T-Cell Ratio · CD8+ T-Cell Count · Erythrocyte Sedimentation Rate (ESR) · Fibrinogen · Growth Differentiation Factor-15 (GDF-15)